Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials
Thierry Landre, G. Justeau, Jean‐Baptiste Assié, Kader Chouahnia, Claire Davoine, Chérifa Taleb, C. Chouaïd, Boris Duchemann
Topics & Concepts
KRASHazard ratioMedicineChemotherapyOncologyInternal medicineLung cancerMeta-analysisCancerConfidence intervalColorectal cancerLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Research Studies